van Diepen, S., Newby, L. K., Lopes, R. D., Stebbins, A., Hasselblad, V., James, S., … Theroux, P. (2012). 726 Acute Phase Inflammatory Biomarkers Add Little Predictive Value to Clinical Factors Plus NT-proBNP Among Patients With ST-Segment Elevation Myocardial Infarction: An Apex AMI Trial Substudy. Canadian Journal of Cardiology, 28(5), S378–S378. https://doi.org/10.1016/j.cjca.2012.07.657

Diepen, S. van, L. K. Newby, R. D. Lopes, A. Stebbins, V. Hasselblad, S. James, M. T. Roe, et al. “726 Acute Phase Inflammatory Biomarkers Add Little Predictive Value to Clinical Factors Plus NT-proBNP Among Patients With ST-Segment Elevation Myocardial Infarction: An Apex AMI Trial Substudy.” Canadian Journal of Cardiology 28, no. 5 (September 2012): S378–S378. https://doi.org/10.1016/j.cjca.2012.07.657.

van Diepen S, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, et al. 726 Acute Phase Inflammatory Biomarkers Add Little Predictive Value to Clinical Factors Plus NT-proBNP Among Patients With ST-Segment Elevation Myocardial Infarction: An Apex AMI Trial Substudy. Canadian Journal of Cardiology. 2012 Sep;28(5):S378–S378.

van Diepen, S., et al. “726 Acute Phase Inflammatory Biomarkers Add Little Predictive Value to Clinical Factors Plus NT-proBNP Among Patients With ST-Segment Elevation Myocardial Infarction: An Apex AMI Trial Substudy.” Canadian Journal of Cardiology, vol. 28, no. 5, Elsevier BV, Sept. 2012, pp. S378–S378. Crossref, doi:10.1016/j.cjca.2012.07.657.

van Diepen S, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, Roe MT, Ezekowitz JA, Moliterno DJ, Neumann F, Reist C, Hochman JS, Mahaffey KW, Hamm CW, Armstrong PW, Granger CB, Theroux P. 726 Acute Phase Inflammatory Biomarkers Add Little Predictive Value to Clinical Factors Plus NT-proBNP Among Patients With ST-Segment Elevation Myocardial Infarction: An Apex AMI Trial Substudy. Canadian Journal of Cardiology. Elsevier BV; 2012 Sep;28(5):S378–S378.